© 2021 RSM US LLP. All rights reserved.
Is going public in your future?
Understand the key considerations, procedures and processes
Trying to decide whether your life sciences company should go public? Operating in the industry’s pharma, biotech and medtech sectors can bring a variety of challenges, not the least of which is raising capital. Launching your initial public offering is a transformative event, and also a complex, distracting and time-consuming transaction that presents high execution risk. Research shows that the most successful public companies started acting like they were public long before the transaction.
A Guide to Going Public includes:
- Guidance on determining whether your company is ready to go public
- Considerations for and against going public
- An overview of the procedures and processes required
- And more!
At RSM, we work with you to understand your business strategy and financial reporting requirements through a public-company lens, evaluate your current internal resources and skills, and help construct a realistic readiness road map for reporting, compliance and more.
We’re here to help you begin your IPO journey. Contact us to learn more.